Axon (AXON) HR chief’s 6,818 stock units lock shares to 2030
Rhea-AI Filing Summary
AXON ENTERPRISE, INC. reported that officer Elizabeth Reid Coughlin, Chief Human Officer, acquired 6,818 shares of common stock in the form of performance-based restricted stock units (XSUs). These units relate to a grant made on December 22, 2023, for which the fourth tranche’s performance conditions were certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period extending to the earlier of December 31, 2030 or the vesting of a subsequent tranche. Following this acquisition, Coughlin holds 40,841.833 shares of Axon common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,818 shares
Net Buy
1 txn
Insider
Coughlin Elizabeth Reid
Role
Chief Human Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 6,818 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 40,841.833 shares (Direct)
Footnotes (1)
- F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.
Key Figures
XSUs acquired: 6,818 shares
Shares held after transaction: 40,841.833 shares
Transaction price per share: $0.0000 per share
+2 more
5 metrics
XSUs acquired
6,818 shares
Performance-based restricted stock units in fourth tranche certified on August 16, 2026
Shares held after transaction
40,841.833 shares
Direct ownership following the reported Form 4 transaction
Transaction price per share
$0.0000 per share
Award of XSUs reported with a zero-dollar per-share transaction price
Tranche vesting date
December 1, 2026
Scheduled vesting date for the fourth tranche of XSUs, subject to continued employment
Minimum holding period end
December 31, 2030
Latest date for minimum holding period on delivered shares, unless a later tranche vests earlier
Key Terms
performance-based restricted stock units, 2024 eXponential Stock Plan, Compensation Committee, minimum holding period
4 terms
performance-based restricted stock units financial
"The transaction consists of performance-based restricted stock units (collectively, "XSUs")"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
2024 eXponential Stock Plan financial
"granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"
Compensation Committee financial
"certified by the issuer's Compensation Committee of the Board of Directors"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
minimum holding period financial
"subject to a minimum holding period until the earlier of (i) December 31, 2030"
FAQ
What did AXON (AXON) disclose about Elizabeth Reid Coughlin’s recent equity award?
AXON disclosed that Elizabeth Reid Coughlin acquired 6,818 performance-based restricted stock units tied to common stock. These units are part of a 2023 grant whose fourth tranche performance conditions were certified as met on August 16, 2026.
When will the new XSUs for AXON’s Elizabeth Reid Coughlin vest?
The fourth tranche of XSUs is scheduled to vest on December 1, 2026, subject to Coughlin’s continued employment. Only after vesting will the underlying shares be delivered, with an additional minimum holding period imposed afterward.
What holding restrictions apply to the new AXON XSUs for Elizabeth Reid Coughlin?
After vesting, the shares from the tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a later tranche, excluding any shares withheld or sold to cover applicable taxes.
What plan governs the AXON XSUs reported for Elizabeth Reid Coughlin?
The XSUs are governed by the Axon Enterprise, Inc. 2024 eXponential Stock Plan. The certified tranche represents the fourth portion of a performance-based award granted under this plan on December 22, 2023.
AI-generated analysis. How Rhea-AI works. Not financial advice.
